3 Biotech Stocks That Soared Past Gilead In 2014
It has been an eventful year for Gilead Sciences Inc. (GILD – Analyst Report), a big name in the biotech sector. Gilead, which soared 100.11% in 2013, is up only around 30% year-to-date (YTD). Throughout 2014, the company was in the news mainly due to its hepatitis C virus (HCV) treatment, Sovaldi, which was approved by the…